Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline

American Journal of Physiology - Endocrinology and Metabolism

Volumn 273, Issue 3 36-3, 1997, Pages

  Frystyk, J ^a   Hussain, M ^b   Skjaerbaek C ^a   Schmitz, O ^a   Christiansen, J S ^a   Froesch, E R ^b   Orskov H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Insulin like growth factor I; Insulin like growth factor binding protein 1; Insulin like growth factor binding protein 3; Recombinant human insulin like growth factor I; Ultrafiltration

Indexed keywords

RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CHROMATOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENZYME SPECIFICITY; FEEDBACK SYSTEM; FEMALE; GLUCOSE CLAMP TECHNIQUE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; MALE; METABOLIC REGULATION; NEGATIVE FEEDBACK; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; ULTRAFILTRATION;

EID: 0030774836     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.273.3.e507     Document Type: Article

References (31)

1. Adamo, M. L. Regulation of insulin-like growth factor-I gene expression: implications for normal and pathological growth. Diabetes Rev. 3: 2-27, 1995.
2. Bar, R. S., M. Boes, D. R. Clemmons, W. H. Busby, A. Sandra, B. L. Drake, and B. A. Booth. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 127: 497-499, 1990.
3. Baxter, R. C. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J. Clin. Endocrinol. Metab. 70: 1347-1353, 1990.
4. Baxter, R. C. Insulin-like growth factor binding proteins as glucoregulators. Metabolism 44: 12-17, 1995.
5. Baxter, R. C., N. Hizuka, K. Takano, S. R. Holman, and K. Asakawa. Responses of insulin-like growth factor binding protein-1 (IGFBP-1) and the IGFBP-3 complex to administration of insulin-like growth factor-I. Acta Endocrinol. 128: 101-108, 1993.
6. Blum, W. F., K. Albertsson Wikland, S. Rosberg, and M. B. Ranke. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab. 76: 1610-1616, 1993.
7. Boulware, S. D., W. V. Tamborlane, L. S. Matthews, and R. S. Sherwin. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E130-E133, 1992.
8. Brismar, K., E. Fernqvist-Forbes, J. Wahren, and K. Hall. Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3 and IGF-I in insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 79: 872-878, 1994.
9. Cheetham, T. D., A. Taylor, J. M. Holly, K. Clayton, S. Cwyfan Hughes, and D. B. Dunger. The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus. J. Endocrinol. 142: 367-374, 1994.
10. Cusi, K., and R. A. DeFronzo. Treatment of NIDDM, IDDM, and other insulin-resistant states with IGF-I. Diabetes Rev. 3: 206-236, 1995.
11. Froesch, E. R., P. D. Zenobi, and M. Hussain. Metabolic and therapeutic effects of insulin-like growth factor I. Horm. Res. 42: 66-71, 1994.
12. Frystyk, J., B. Dinesen, and H. Ørskov. Non-competitive time-resolved immunofluorometric assay for determination of human insulin-like growth factor I and II. Growth Regul. 5: 169-176, 1995.
13. Frystyk, J., C. Skjærbæk, B. Dinesen, and H. Ørskov. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348: 185-191, 1994.
14. Frystyk, J., E. Vestbo, C. Skjærbæk, C. E. Mogensen, and H. Ørskov. Free insulin-like growth factors in human obesity. Metabolism 44, Suppl. 4: 37-44, 1995.
15. Guler, H. P., C. Schmid, J. Zapf, and E. R. Froesch. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc. Natl. Acad. Sci. USA 86: 2868-2872, 1989.
16. Guler, H. P., J. Zapf, and E. R. Froesch. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N. Engl. J. Med. 317: 137-140, 1987.
17. Gundersen, H. J. G., and N. J. Christensen. Intravenous insulin causing loss of intravascular water and albumin and increased adrenergic nervous activity in diabetics. Diabetes 26: 551-557, 1977.
18. Hartman, M. L., P. E. Clayton, M. L. Johnson, A. Celniker, A. J. Perlman, K. G. Alberti, and M. O. Thorner. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J. Clin. Invest. 91: 2453-2462, 1993.
19. Hussain, M. A., O. Schmitz, J. S. Christiansen, N. J. Christensen, K. G. M. M. Alberti, and E. R. Froesch. IGF-I alters skeletal muscle substrate metabolism and blunts recovery from insulin-induced hypoglycemia. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E545-E551, 1996.
20. Hussain, M. A., O. Schmitz, A. Mengel, Y. Glatz, J. S. Christiansen, J. Zapf, and E. R. Froesch. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J. Clin. Invest. 94: 1126-1133, 1994.
21. Hussain, M. A., O. Schmitz, A. Mengel, A. Keller, J. S. Christiansen, J. Zapf, and E. R. Froesch. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J. Clin. Invest. 92: 2249-2256, 1993.
22. Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1995.
23. Juul, A., A. Flyvbjerg, J. Frystyk, J. Müller, and N. E. Skakkebæk. Serum concentrations of free and total insulin-like growth factor-I, IGF-binding protein-1 and -3 and IGFBP-3 protease activity in boys with normal and precocious puberty. Clin. Endocrinol. (Oxf.) 44: 515-523, 1996.
24. Kupfer, S. R., L. E. Underwood, R. C. Baxter, and D. R. Clemmons. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J. Clin. Invest. 91: 391-396, 1993.
25. Lieberman, S. A., J. Bukar, S. A. Chen, A. C. Celniker, P. G. Compton, J. Cook, J. Albu, A. J. Perlman, and A. R. Hoffman. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J. Clin. Endocrinol. Metab. 75: 30-36, 1992.
26. Rosenfeld, R. G., J. Guevara-Aguirre, S. E. Gargosky, and A. L. Rosenbloom. IGF-I treatment of syndromes of growth hormone insensitivity. In: The Insulin-Like Growth Factors and Their Regulatory Proteins, edited by R. C. Baxter, P. D. Gluckman, and R. G. Rosenfeld. Amsterdam: Excerpta Medica, 1994, p. 457-463.
27. Scharf, J. G., W. Schmidt Sandte, S. A. Pahernik, H. G. Koebe, and H. Hartmann. Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit of the insulin-like growth factor ternary binding protein complex in primary cultures of human hepatocytes. J. Hepatol. 23: 424-430, 1995.
28. Takano, K., N. Hizuka, K. Shizume, K. Asakawa, I. Fukuda, and H. Demura. Repeated sc administration of recombinant human insulin-like growth factor I (IGF-I) to human subjects for 7 days. Growth Regul. 1: 23-28, 1991.
29. Young, S. C., and D. R. Clemmons. Changes in insulin-like growth factor (IGF)-binding proteins after IGF-I injections in noninsulin-dependent diabetics. J. Clin. Endocrinol. Metab. 78: 609-614, 1994.
30. Young, S. C., L. E. Underwood, A. Celniker, and D. R. Clemmons. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J. Clin. Endocrinol. Metab. 75: 603-608, 1992.
31. Zenobi, P. D., S. Graf, H. Ursprung, and E. R. Froesch. Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J. Clin. Invest. 89: 1908-1913, 1992.